Advertisement

Modulation of an Estrogen-Induced Protein in the MCF7 Human Mammary Cancer Cell

  • Henri Rochefort
Part of the Biochemical Endocrinology book series (BIOEND)

Abstract

Estrogens are able to induce two series of responses in a given target tissue. First, they increase cell proliferation and stimulate the general metabolism of the cells by favoring their entry into an active G1 step of the cell cycle (pleiotypic effect) (Herschko et al., 1971). Secondly, they stimulate the biosynthesis of specific proteins. The mechanism of the pleiotypic effect is poorly understood and may involve common intermediary steps between the binding of the receptor in the nucleus and the final responses. In any case, this pleiotypic effect can also be triggered by other hormones and is therefore not specific for estrogens.

Keywords

Estrogen Receptor MCF7 Cell Human Breast Cancer Cell Line MCF7 Human Breast Cancer Cell Estrogen Receptor Binding 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams, D. J., Edwards, D. P., and Mc Guire, W. L., 1980, Estrogen regulation of specific messenger RNA’s in human breast cancer cells, Biochem. Biophys. Res. Commun. 97: 1354.CrossRefGoogle Scholar
  2. Adams, J., Garcia, M., and Rochefort, H., 1981, Estrogenic effects of physiological concentrations of 5-androstene-313, 1713-diol and its metabolism in MCF7 human breast cancer cells, Cancer Res. 41: 4720.Google Scholar
  3. André, J., Vic, P., Humeau, C., and Rochefort, H., 1977, Nuclear translocation of the estradiol receptor: Partial inhibition by ethidium bromide, Mol. Cell. Endocrinol. 8: 225.CrossRefGoogle Scholar
  4. Blue, M. L., and Williams, D. L., 1981, Induction of avian serum apolipoprotein II and vitellogenin by tamoxifen, Biochem. Biophys. Res. Commun. 98: 785.CrossRefGoogle Scholar
  5. Borgna, J. L., and Rochefort, H., 1980, High-affinity binding to the estrogen receptor of 3H 4- hydroxytamoxifen, and active antiestrogen metabolite, Mol. Cell. Endocrinol. 20: 71.CrossRefGoogle Scholar
  6. Borgna, J. L., and Rochefort, H., 1981, Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target, J. Biol. Chem. 256: 859.PubMedGoogle Scholar
  7. Bouton, M. M., and Raynaud, J. P., 1978, The relevance of kinetic parameters in the determination of specific binding to the estrogen receptor, J. Steroid Biochem. 9: 9.PubMedCrossRefGoogle Scholar
  8. Capony, F., and Williams, D. L., 1981, Antiestrogen action in avian liver: The interaction of estrogens and antiestrogens in the regulation of apolipoprotein B synthesis, Endocrinology 108: 1862.Google Scholar
  9. Chalbos, D., Vignon, F., and Rochefort, H., 1982, Effect of estrogen on cell proliferation and secretory proteins in the T47D human breast cancer cell line, Cold Spring Harbor Conference on Cell Proliferation, Vol. 9, p. 845, Cold Spring Harbor Laboratory, New York.Google Scholar
  10. Clark, J., Baulieu, E. E., Baxter, J. D., de Crombrugghe, B., Jorgenson, E. C., Katzenellenbogen, B. S., Katzenellenbogen, J. A., Luebke, K., Moran, J., Rochefort, H., Sherman, M. R., and Ripen, M., 1976, in: Intracellular receptors group report, Hormone and Antihormone Action at the Target Cell, Dahlem Konferenzen, Life Science Research Report (J. H. Clark, W. Klee, A. Levitzki, and J. Wolff, eds.), pp. 147–169, Berlin.Google Scholar
  11. Coezy, E., Borgna, J. L., and Rochefort, H., 1982, Tamoxifen and metabolites in MCF7 cells: Binding to estrogen receptor and cell growth inhibition, Cancer Res. 41: 317.Google Scholar
  12. Evans, E., Baskevitch, P. P., and Rochefort, H., 1982, Estrogen receptor DNA interaction: Difference between activation by estrogen and antiestrogen, Eur. J. Biochem. 128: 185.PubMedCrossRefGoogle Scholar
  13. Garcia, M., and Rochefort, H., 1977, Androgens on the estrogen receptor. II. Correlation between nuclear translocation and uterine protein synthesis, Steroids 29: 111.PubMedCrossRefGoogle Scholar
  14. Garcia, M., and Rochefort, H., 1978, Androgen effects mediated by the estrogen receptor in 7,12 dimethylbenz(a)anthracene-induced rat mammary tumors, Cancer Res. 38: 3922.PubMedGoogle Scholar
  15. Garcia, M., Westley, B., and Rochefort, H., 1981, 5-Bromodeoxyuridine specifically inhibits the synthesis of estrogen-induced proteins in MCF, cells, Eur. J. Biochem. 116: 297.Google Scholar
  16. Herschko, A., Mamont, P., Shields, R., and Tomkins, G. M., 1971, Pleiotypic response, Nature New Biol. 232: 206.Google Scholar
  17. Horwitz, K. B., and Mc Guire, W. L., 1978, Estrogen control of progesterone receptor in human breast cancer, J. Biol. Chem. 253: 2223.PubMedGoogle Scholar
  18. Kallos, J., Hollander, V. P., Fasy, T. M., and Bick, M. D., 1978, Estrogen receptor binds more tightly to bromodeoxyuridine-substituted DNA, Proc. Natl. Acad. Sci. U.S.A. 75: 4896.PubMedCrossRefGoogle Scholar
  19. Lippman, M., Bolan, G., and Huff, K., 1976, The effects of estrogens and antiestrogens on hormone responsive human breast cancer in long-term tissue culture, Cancer Res. 36: 4595.PubMedGoogle Scholar
  20. McGuire, W. L., 1980, Steroid hormone receptor in breast cancer treatment strategy, in: Recent Progress in Hormone Research ( R. O. Greep, ed.), Vol. 36, pp. 135–156, Academic Press, New York.Google Scholar
  21. Notides, A., and Gorski, J., 1966, Estrogen-induced synthesis of a specific uterine protein, Proc. Natl. Acad. Sci. U.S.A. 56: 230.CrossRefGoogle Scholar
  22. O’Farrell, P. H., 1975, High resolution two-dimensional electrophoresis proteins, J. Biol. Chem. 10: 4007.Google Scholar
  23. Palmiter, R. D., Mulvihill, E. R., Mc Knight, G. S., and Senear, A. W., 1978, Regulation of gene expression in the chick oviduct by steroid hormones, Cold Spring Harbor Symp. Quant. Biol. 42: 639–647.Google Scholar
  24. Rochefort, H., and Borgna, J. L., 1981, Differences between estrogen receptor activation by estrogen and antiestrogen, Nature 292: 257.PubMedCrossRefGoogle Scholar
  25. Rochefort, H., and Capony, F., 1973, Etude comparée du comportement d’un antioestrogène et de l’oestradiol dans les cellules utérines, C. R. Acad. Sci. Paris 276: 2321.Google Scholar
  26. Rochefort, H., Garcia, M., Vignon, F., and Westley, B., 1980, Proteins induced by the estrogen receptor in uterus and breast cancer cells, in: Steroid Induced Uterine Proteins ( M Beato, ed.), pp. 171–181, Elsevier,North-Holland Biomedical Press, Amsterdam.Google Scholar
  27. Rochefort, H., Capony, F., and Borgna, J. L., 1981a, Metabolism and binding of non-steroidal antiestrogen in mammals and chicken, in: Non-Steroidal Antiestrogens ( R. L. Sutherland and V. C. Jordan, eds.), pp. 85–94, Harcourt Brace Jovanovitch Group (Australia), Academic Press, Sydney.Google Scholar
  28. Rochefort, H., Coezy, E., Joly, E., Westley, B., and Vignon, F., 1981b, Hormonal control of breast cancer in cell culture, in: Hormones and Cancer ( S. Iacobelli, R. J. B. King, H. R. Lindner, and M. E. Lippman, eds.), pp. 21–29, Raven Press, New York.Google Scholar
  29. Ruh, T. S., and Ruh, M. F., 1975, Androgen induction of a specific uterine protein, Endocrinology 97: 1144.PubMedCrossRefGoogle Scholar
  30. Shyamala, G., and Leonard, L. J., 1980, Inhibition of uterine estrogen receptor transformation by sodium molybdate, J. Biol. Chem. 255: 6028.Google Scholar
  31. Sibley, C. H., and Tomkins, G. M., 1974, Mechanism of steroid resistance, Cell 2: 221.PubMedCrossRefGoogle Scholar
  32. Sirbasku, D. A., and Benson, R. H., 1979, Estrogen-inducible growth factors that may act as mediators (estromedins) of estrogen-promoted tumor cell growth, in: Hormones and Cell Culture Cold Spring Harbor Conferences on Cell Proliferation ( G. Sato and R. Ross, eds.), Vol. 6, p. 477–497, Cold Spring Harbor Laboratory, New York.Google Scholar
  33. Sonnenschein, C., and Soto, A. M., 1980, Butchr(133) Are estrogens per se growth-promoting hormones ?, J. Natl. Cancer Inst. 64: 211.PubMedGoogle Scholar
  34. Sutherland, R., Mester, J., and Baulieu, E. E., 1977, Tamoxifen is a potent “pure” antiestrogen in chick oviduct, Nature 267: 434.PubMedCrossRefGoogle Scholar
  35. Sutherland, R. L., Murphy, L. C., Foo, M. S., Green, M. D., and Whybourne, A. M., 1980, High-affinity antiestrogen binding site distinct from the estrogen receptor, Nature 288: 273.PubMedCrossRefGoogle Scholar
  36. Westley, B., and Rochefort, H., 1979, Estradiol induced proteins in the MCF, human breast cancer cell line, Biochem. Biophys. Res. Commun. 90: 410.CrossRefGoogle Scholar
  37. Westley, B., and Rochefort, H., 1980, A secreted glycoprotein induced by estrogen in human breast cancer cell lines, Cell 20: 352.CrossRefGoogle Scholar
  38. Westley, B., Vignon, F., Garcia, M., and Rochefort, H., (1980), A 46 K estrogen induced protein secreted by human breast cancer cells in culture. Second International Congress on Cell Biology, August 31—September 5, 1980, West Berlin.Google Scholar
  39. Zava, D. T., and McGuire, W. L., 1978, Human breast cancer: Androgen action mediated by estrogen receptor, Science 199: 787.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Henri Rochefort
    • 1
  1. 1.Unité d’Endocrinologie Cellulaire et MoléculaireU 148 INSERMMontpellierFrance

Personalised recommendations